- Case report
- Open Access
Riedel's thyroiditis - a case report with genes' expression studies
© Wojciechowska-Durczyńska et al; licensee BioMed Central Ltd. 2012
- Received: 17 January 2012
- Accepted: 7 March 2012
- Published: 7 March 2012
Genetic background of Riedel's thyroiditis remains unknown. Herein, we describe our results of studies on genes expression levels in Riedel's thyroiditis.
Case report and genetic findings
We report the case of 48-year old woman with Riedel's thyroiditis who has presented unusual course of disease with non-specific cervical discomfort, though as with no pain and/or no compression symptoms. After surgery, thyroid specimens were quantitatively evaluated, regarding PIK3CA, PIK3CD, PIK3CG, Tg, TGFB1, THRB, COL1, CDKN1C, CDH3 and CACNA2D2 genes expression levels, by real-time PCR in the ABI PRISM® 7500 Sequence Detection System. Out of 10 above genes, in 2 cases the expression was higher than in respective Controls of unchanged thyroid tissue. In the remaining 8 cases, expression in question became comparable or lower as in Controls.
The association between increased expression levels of PIK3CA and CDH3 genes and Riedel's thyroiditis is not well-defined. However, the increased expression of PIK3CA and CDH3 genes in our case report and in previous studies of other authors on various malignancies may suggest possible molecular relation between Riedel's thyroiditis and certain neoplastic processes, the relation of which requires further genetic evaluation. It is to be stressed that gene expression studies in Riedel's thyroiditis are difficult to perform, mainly due to fibrosis, resulting in scarce thyroid specimens and - in consequence - small amount of genetic material.
- Riedel's thyroiditis
- Genes' expression
- Real-time PCR
Riedel's thyroiditis is a rare fibrosclerotic infiltrative thyroid disorder of unclear etiology, during which normal thyroid tissues are replaced by fibrous tissue, often expanding outside the thyroid capsule. The diagnosis can be difficult to establish prior to surgical removal of the thyroid and to subsequent histopathological examination of the resected gland [1–3]. Reports on genetic findings in Riedel's thyroiditis are scarce in medical literature. Herein, we describe our results of studies on genes expression levels in Riedel's thyroiditis.
After surgery, following conventional histopathological examination, thyroid specimen, received from patient with Riedel's thyroiditis, was quantitatively evaluated regarding PIK3CA, PIK3CD, PIK3CG, Tg, TGFB1, THRB, COL1, CDKN1C, CDH3 and CACNA2D2 genes expression levels by real-time PCR in the ABI PRISM ®7500 Sequence Detection System. Macroscopically unchanged thyroid tissue, surgically removed from the patient with non-toxic nodular goitre (NTG), served as a control for real-time PCR experiment.
Total RNA from tissue was extracted by use of an RNeasy Midi Kit (Qiagen, Hilden, Germany) based on modified Chomczyński and Sacchi's according to manufacturers' recommendations. The purity of total RNA was assessed by NanoDrop® ND-100 spectrophotometr and next the RNA was used in the first strand cDNA synthesis with TaqMan® Reverse Transcripton Reagents (Applied Biosystem) according to maufacturers' instruction. Real-time PCR was performed by using Taq Man® Universal PCR Master Mix (Applied Biosystem) and Taq Man® Gene Expression Assays probe and primer mix (Applied Biosystem) according to the manufacturer' specification. Thermal cycler conditions were as follows: hold for 10 min. at 95°C, follow by two-step PCR for 50 cycles of 95°C for 15 s followed by 60°C for 1 min. Amplification reactions, in triplicate for each sample, were performed and the results were normalized to the ACTB gene expression level.
An analysis of relative gene expression data was performed, using the 2-ΔΔCT method on an ABI PRISM® 7500 Sequence Detection System Software. The fold change in studied gene expression, normalised to endogenous control, was calculated using: RQ = 2-ΔΔCT.
Riedel's throiditis is a rare disease that most commonly occurs in females in their fifties and usually demonstrates as a goitre without clinical evidence of thyroid nodules. On palpation, thyroid demonstrates firm or stony consistency ("iron-hard thyroiditis"). Symptoms of regional compression might progressively appear. However, the clinical course of this disease is mostly variable and may include cases with no thyroid-related symptoms, as we have noted in our patient . Before surgery, Riedel's thyroiditis is often difficult to differentiate from aggressive types of thyroid cancers (i.e., undifferentiated thyroid carcinoma), nevertheless, a long-term follow-up shows no disease-specific mortality . Likewise in presented patient, in vast majority of cases, only histopathological, postoperative examination leads to diagnosis of Riedel's thyroiditis, due to no specific symptoms. Cytological evaluation is also of limited use in Riedel's thyroiditis, due to firm thyroid tissue consistency and scanty amount of cellular material thus often non-diagnostic thyroid specimens . According to our opinion, in the case described by us, unusual course of the Riedel's thyroiditis with the absence of compressive symptoms may be related to early-stage of the disease.
A number of hypotheses have been proposed regarding etiology and pathogenesis of Riedel's thyroiditis. The disease may be associated with subacute and chronic thyroiditis, thus some authors proposed the, so called, "intrathyroidal hypothesis". According to that hypothesis, the entity may represent the late stage (i.e., the progression to fibrotic stage) of chronic inflammatory disorder [6–8]. On the contrary, the "pharmacological hypothesis" suggests that some particular medications may trigger Riedel's thyroiditis development . Although not proven, inherited susceptibility and development was hypothesized, as well . Nowadays, the "systemic autoimmune hypothesis" seems to have the most support and it basically views Riedel's thyroiditis as a manifestation of disordered fibroplastic proliferation because of hypersensivity reaction and consequent release of stimulating growth factors . This theory considers a fibroblast not only as a final cell responsible for fibrosis, but also as a main target for well-defined systemic autoimmune attack . In our case, the "systemic autoimmune hypothesis" of Riedel's thyroiditis is the most plausible, it is supported by laboratory findings of autoimmune thyroid disease (anti-Tg), which have persisted after surgery.
PI3K/Akt (phosphoinositide 3-kinase/serine-threonine protein kinase) pathway participates in cellular signaling in response to various growth factors including FGF (fibroblast growth factor). Activating mutations and amplification of PIK3CA gene have been associated with enhancing PIK3CA kinase activity and Akt phosphorylation. Increased PI3K/Akt expression has been observed in both Hashimoto thyroiditis and well-differentiated thyroid cancer [10, 11]. Still, little is known about the precise role of PIK3CA in fibrosclerotic disorders, however, it has been proved that hepatic Akt expression correlated with advanced liver fibrosis in chronic hepatitis C patient .
Our results demonstrate that CDH3 gene expression may increase in Riedel's thyroiditis, as well. Cadherins, such as CDH3, are integral membrane glycoproteins responsible for calcium-dependent cell-cell adhesion. Our contemporary knowledge about the role of P-cadherin in fibrosis and autoimmune processes is scanty and, so far, it has been only demonstrated that aberrant expression of E-cadherin/β-catenin complex is associated with a wide variety of human malignancies and fibrosis .
The association between increased expression levels of PIK3CA and CDH3 genes and Riedel's thyroiditis is not well-defined. However, the increased expression of PIK3CA and CDH3 genes in our case report and in previous studies of other authors on various malignancies may suggest possible molecular relation between Riedel's thyroiditis and certain neoplastic processes, the relation which requires further genetic evaluation.
Low expression levels of the remaining studied genes could be associated with destruction of glandular thyroid tissue. The levels of TGFB1, COL1 and CDKN1C genes expression were comparable in Riedel's thyroiditis and in macroscopically unchanged tissue. It is to be emphasized that high expression levels of TGFB1 and of COL1A1 genes in chronic thyroiditis and its correlation with thyroid fibrosis has previously been observed . These results call into question the "intrathyroidal hypothesis" of Riedel's disease pathogenesis. One should remind once again that gene expression studies in Riedel's thyroiditis are difficult to perform, mainly due to fibrosis, resulting in scarce thyroid specimens and - in consequence - small amount of genetic material.
Written informed consent was obtained from the patient for publication of this report and any accompanying images.
- Schwaegerle SM, Bauer TW, Esselstyn CB Jr: Riedel's thyroiditis. Am J Clin Pathol 1988, 6: 715–722. ReviewGoogle Scholar
- Papi G, Corrado S, Cesinaro AM, Novelli L, Smerieri A, Carapezzi C: Riedel's thyroiditis: clinical, pathological and imaging features. Int J Clin Pract 2002, 1: 65–67.Google Scholar
- Fontaine S, Gaches F, Lamant L, Uzan M, Bennet A, Caron P: An unusual form of Riedel's thyroiditis: a case report and review of the literature. Thyroid 2005, 1: 85–88.View ArticleGoogle Scholar
- Fatourechi MM, Hay ID, McIver B, Sebo TJ, Fatourechi V: Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976–2008. Thyroid 2011, 7: 765–772.View ArticleGoogle Scholar
- Junik R, Juraniec O, Pypkowski J, Krymer A, Marszałek A: A difficult diagnosis: a case report of combined Riedel's disease and fibrosing Hashimoto's thyroiditis. Endokrynol Pol 2011,62(4):351–356.PubMedGoogle Scholar
- Zelmanovitz F, Zelmanovitz T, Beck M, Cerski CT, Schmid H, Czepielewski MA: Riedel's thyroiditis associated with high titers of antimicrosomal and antithyroglobulin antibodies and hypothyroidism. J Endocrinol Invest 1994, 9: 733–737.View ArticleGoogle Scholar
- Papi G, Corrado S, Carapezzi C, De-Gaetani C, Carani C: Riedel's thyroiditis and fibrous variant of Hashimoto's thyroiditis: a clinicopathological and immunohistochemical study. J Endocrinol Invest 2003, 5: 444–449.View ArticleGoogle Scholar
- Papi G, LiVolsi VA: Current concepts on Riedel thyroiditis. Am J Clin Pathol 2004, 121: 50–63.Google Scholar
- Biddinger PW: Thyroiditis. In Diagnostic Pathology and molecular Genetics of the Thyroid. Edited by: Nikiforov YE. Lippincott Williams & Wilkins; 2009:39–59.Google Scholar
- Larson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S, Evers BM: Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 2007, 5: 764–773.View ArticleGoogle Scholar
- Wojciechowska-Durczyńska K, Krawczyk-Rusiecka K, Cyniak-Magierska A, Zygmunt A, Gałecka E, Lewiński A: Relative quantification of PIK3C gene expression level in fine-needle aspiration biopsy thyroid specimens collected from patients with papillary thyroid carcinoma and non-toxic goitre by real-time RT-PCR. Thyroid Res 2010, 3: 5. 10.1186/1756-6614-3-5PubMed CentralPubMedView ArticleGoogle Scholar
- Huang JF, Chuang YH, Dai CY, Yu ML, Huang CF, Hsiao PJ, Hsieh MY, Huang CI, Yeh ML, Yang JF, Lin ZY, Chen SC, Chuang WL: Hepatic Akt expression correlates with advanced fibrosis in patients with chronic hepatitis C infection. Hepatol Res 2011, 5: 430–436.View ArticleGoogle Scholar
- Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR, Zhao Y, Harris DC, Zheng G: E-cadherin/β-catenin complex and the epithelial barrier. J Biomed Biotechnol 2011, 2011: 567305.PubMed CentralPubMedGoogle Scholar
- Cyniak-Magierska A, Januszkiewicz-Caulier J, Brzeziańska E, Lewiński A: Analysis of correlation between the process of thyroid fibrosis and TGFB1 gene expression level in fine-needle aspiration biopsy (FNAB) thyroid specimens collected from patients with Hashimoto's thyroiditis and non-toxic goitre. Exp Clin Endocrinol Diabetes 2010, 7: 420–426.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.